Arbutus Biopharma Corporation (ABUS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arbutus Biopharma Corpora...

    NASDAQ: ABUS · Real-Time Price · USD
    4.64
    -0.26 (-5.31%)
    At close: Sep 12, 2025, 11:56 AM

    Arbutus Biopharma Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -8.68 -5.7 -5.06 -5.34
    PEG Ratio
    		 0.64 1.31 0.14 0.35
    PS Ratio
    		 98.35 22.87 9.01 37.61
    PB Ratio
    		 6.23 3.91 2.57 2.44
    P/FCF Ratio
    		 -9.33 -4.77 -9.81 -6.05
    P/OCF Ratio
    		 -9.36 -4.83 -9.95 -6.12
    OCF/S Ratio
    		 -10.51 -4.74 -0.91 -6.15
    Debt / Equity Ratio
    		 0.01 0.08 0.02 0.02
    Quick Ratio
    		 8.15 5.87 4.69 14.71
    Current Ratio
    		 8.15 5.87 4.60 14.32
    Asset Turnover
    		 0.05 0.13 0.20 0.05
    Interest Coverage
    		 -557.07 -170.16 -37.92 -25.73
    Return on Equity
    		 -0.72 -0.69 -0.51 -0.46
    Return on Assets
    		 -0.53 -0.5 -0.36 -0.38
    Return on Invested Capital
    		 -0.65 -0.64 -0.43 -0.38
    Dividend Yield
    		 n/a n/a n/a 0.03
    Payout Ratio
    		 n/a n/a n/a -0.16
    Gross Profit Margin
    		 0.78 -3.06 0.96 0.84
    Net Profit Margin
    		 -11.33 -4.02 -1.78 -7.04
    Pretax Profit Margin
    		 -11.33 -4.02 -1.67 -6.94
    Operating Profit Margin
    		 -12.37 -4.31 -1.68 -6.69
    FCF Margin
    		 -10.54 -4.79 -0.92 -6.22
    EBITDA Margin
    		 -11.08 -3.91 -1.59 -6.52

    Add to Watchlist